Evidence map›Paper›PMID 26910733›Full record

ArticlePloS one2016

Testosterone and Androgen Receptor Sensitivity in Relation to Hyperactivity Symptoms in Boys with Autism Spectrum Disorders.

Anna Pivovarciova, Jaroslava Durdiakova, Katarina Babinska, Aneta Kubranska, Lenka Vokalova, Gabriel Minarik, Peter Celec, Marianna Murin, Daniela Ostatnikova

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Potential of Salivary Biomarkers in Autism Research: A Systematic Review.International journal of molecular sciences · 2021
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Autism-Like Behavior in the Offspring ofFrontiers in neuroscience · 2021
    Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Anna PivovarciovaAcademic Research Center for Autism, Institute of Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Jaroslava DurdiakovaAcademic Research Center for Autism, Institute of Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Katarina BabinskaAcademic Research Center for Autism, Institute of Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Aneta KubranskaAcademic Research Center for Autism, Institute of Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Lenka VokalovaAcademic Research Center for Autism, Institute of Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Gabriel MinarikDepartment of Molecular Biology, Faculty of Natural Sciences, Comenius University, Bratislava, Slovakia.
Peter CelecInstitute of Molecular Biomedicine, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Marianna MurinDepartment of Child and Adolescent Mental Health, Social Communication Disorders Clinic, Great Ormond Street Hospital for Children, London, United Kingdom.
Daniela OstatnikovaAcademic Research Center for Autism, Institute of Physiology, Faculty of Medicine, Comenius University, Bratislava, Slovakia.
Comenius University Bratislava · SKGreat Ormond Street Hospital · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionAutism spectrum disorders (ASD) and hyperactivity symptoms exhibit an incidence that is male-biased. Thus androgen activity can be considered a plausible biological risk factor for these disorders. However, there is insufficient information about the association between increased androgen activity and hyperactivity symptoms in children with ASD.

methodsIn the present study, the relationship between parameters of androgenicity (plasmatic testosterone levels and androgen receptor sensitivity) and hyperactivity in 60 boys (age 3-15) with ASD is investigated. Given well documented differences in parent and trained examiners ratings of symptom severity, we employed a standardized parent`s questionnaire (Nisonger Child Behavior Rating Form) as well as a direct examiner`s rating (Autism diagnostic observation schedule) for assessment of hyperactivity symptoms.

resultsAlthough it was found there was no significant association between actual plasmatic testosterone levels and hyperactivity symptoms, the number of CAG triplets was significantly negatively correlated with hyperactivity symptoms (R2 = 0.118, p = 0.007) in the sample, indicating increased androgen receptor sensitivity in association with hyperactivity symptoms. Direct trained examiner´s assessment appeared to be a relevant method for evaluating of behavioral problems in the investigation of biological underpinnings of these problems in our study.

conclusionsA potential ASD subtype characterized by increased rates of hyperactivity symptoms might have distinct etiopathogenesis and require a specific behavioral and pharmacological approach. We propose an increase of androgen receptor sensitivity as a biomarker for a specific ASD subtype accompanied with hyperactivity symptoms. Findings are discussed in terms of their implications for practice and future research.

Indexed as

Child BehaviorAdolescentAutism Spectrum DisorderBiomarkersChildChild, PreschoolHumansHyperkinesisMaleReceptors, AndrogenSurveys and QuestionnairesTestosteroneTrinucleotide RepeatsAR protein, humanBiomarkersReceptors, AndrogenTestosterone

Identifiers

PMID26910733
PMCPMC4765851
OpenAlexW2282502386

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.